1087 / 1851
Faivre-Finn C. et al. BMJ 2016;6
3) Ongoing study on the role of altered fractionation:
the CONVERT trial
Phase III randomized trial
447 patients enrolled, accrual closed,
results expected very soon.
The
results will be crucial
in
determining the best standard
regimen for LD-SCLC
Higher dose of radiation
in the
“once-daily” arm, compared to the
hyperfractionated one (66 Gy vs 45)
Primary endpoint: OS